{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:24Z","timestamp":1790109804249,"version":"4.0.1"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.2169\/internalmedicine.7990-21","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T22:09:50Z","timestamp":1628806190000},"page":"755-759","source":"Crossref","is-referenced-by-count":27,"title":["Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab"],"prefix":"10.2169","volume":"61","author":[{"given":"Miki","family":"Ikeda","sequence":"first","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuharu","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiko","family":"Shiina","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kitani","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Suzukawa","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy 68: 261-273, 2013.","DOI":"10.1111\/all.12088"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol 5: 549, 2014.","DOI":"10.3389\/fimmu.2014.00549"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet 361: 587-594, 2003.","DOI":"10.1016\/S0140-6736(03)12518-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 22: 21-28, 2010.","DOI":"10.1097\/BOR.0b013e328333390b"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63: 65-81, 1984.","DOI":"10.1097\/00005792-198403000-00001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov 15: 35-50, 2016.","DOI":"10.1038\/nrd4624"},{"key":"7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"7. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2) LEN and AllerGen). Allergy 63: 8-160, 2008.","journal-title":"Allergy","ISSN":"https:\/\/id.crossref.org\/issn\/0105-4538","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394: 1638-1650, 2019.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33: 1094-1100, 1990.","DOI":"10.1002\/art.1780330806"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sada KE, Amano K, Uehara R, et al. A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol 24: 640-644, 2014.","DOI":"10.3109\/14397595.2013.857582"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int 68: 430-436, 2019.","DOI":"10.1016\/j.alit.2019.06.004"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hervier B, Masseau A, Bossard C, Agard C, Hamidou M. Vasa-vasoritis of the aorta and fatal myocarditis in fulminant Churg-Strauss syndrome. Rheumatology 47: 1728-1729, 2008.","DOI":"10.1093\/rheumatology\/ken329"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Setoguchi M, Okishige K, Sugiyama K, et al. Sudden cardiac death associated with Churg-Strauss syndrome. Circ J 73: 2355-2359, 2009.","DOI":"10.1253\/circj.CJ-08-0926"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65: 270-281, 2013.","DOI":"10.1002\/art.37721"},{"key":"15","unstructured":"15. Cottin V, Bel E, Bottero P, et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d&apos;Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 16: 1-9, 2017."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 279: 455-457, 1998.","DOI":"10.1001\/jama.279.6.455"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L. Churg-Strauss syndrome in patients treated with omalizumab. Chest 136: 507-518, 2009.","DOI":"10.1378\/chest.08-2990"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ho\u010devar A, Kopa\u010d P, Rotar \u017d, Novljan MP, \u0160krgat S. Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab. J Allergy Clin Immunol Pract 8: 2448-2449, 2020.","DOI":"10.1016\/j.jaip.2020.04.006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liu LY, Sedgwick JB, Bates ME, et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 169: 6452-6458, 2002.","DOI":"10.4049\/jimmunol.169.11.6452"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakamura Y, Azuma M, Okano Y, et al. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte\/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol 15: 680-687, 1996.","DOI":"10.1165\/ajrcmb.15.5.8918375"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Noguchi T, Nakagome K, Kobayashi T, et al. Periostin upregulates the effector functions of eosinophils. J Allergy Clin Immunol 138: 1449-1452.e5, 2016.","DOI":"10.1016\/j.jaci.2016.05.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Fujisawa T, Kato Y, Nagase H, et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 106: 507-513, 2000.","DOI":"10.1067\/mai.2000.108311"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sidhu SS, Yuan S, Innes AL, et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 107: 14170-14175, 2010.","DOI":"10.1073\/pnas.1009426107"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Stellato C, Matsukura S, Fal A, et al. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol 163: 5624-5632, 1999.","DOI":"10.4049\/jimmunol.163.10.5624"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rabe KF, Nair P, Brusselle G, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378: 2475-2485, 2018.","DOI":"10.1056\/NEJMoa1804093"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378: 2486-2496, 2018.","DOI":"10.1056\/NEJMoa1804092"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Menzella F, Montanari G, Patricelli G, et al. A case of chronic eosinophilic pneumonia in a patient treated with dupilumab. Ther Clin Risk Manag 15: 869-875, 2019.","DOI":"10.2147\/TCRM.S207402"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Eger K, Pet L, Weersink EJM, Bel EH. Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma. J Allergy Clin Immunol Pract 9: 2913-2915, 2021.","DOI":"10.1016\/j.jaip.2021.02.042"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/5\/61_7990-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T07:26:10Z","timestamp":1673076370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/5\/61_7990-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7990-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"article-number":"7990-21"}}